JP2025502098A5 - - Google Patents
Info
- Publication number
- JP2025502098A5 JP2025502098A5 JP2024541046A JP2024541046A JP2025502098A5 JP 2025502098 A5 JP2025502098 A5 JP 2025502098A5 JP 2024541046 A JP2024541046 A JP 2024541046A JP 2024541046 A JP2024541046 A JP 2024541046A JP 2025502098 A5 JP2025502098 A5 JP 2025502098A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- approximately
- patient
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263298067P | 2022-01-10 | 2022-01-10 | |
| US63/298,067 | 2022-01-10 | ||
| PCT/IB2023/050172 WO2023131922A1 (en) | 2022-01-10 | 2023-01-09 | Compositions and methods for the treatment of depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502098A JP2025502098A (ja) | 2025-01-24 |
| JP2025502098A5 true JP2025502098A5 (cg-RX-API-DMAC7.html) | 2026-01-19 |
Family
ID=84981591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541046A Pending JP2025502098A (ja) | 2022-01-10 | 2023-01-09 | うつ病の治療のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250090482A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4463144A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025502098A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118524832A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3247226A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023131922A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4687860A1 (en) * | 2023-03-24 | 2026-02-11 | Janssen Pharmaceutica NV | Esketamine for use in the treatment of depression |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19723133A1 (de) | 1997-06-03 | 1998-12-10 | Caideil M P Teoranta Tourmakea | Austragvorrichtung für Medien |
| JP2022548233A (ja) * | 2019-09-13 | 2022-11-17 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | エスケタミンの鼻腔内投与 |
-
2023
- 2023-01-09 CA CA3247226A patent/CA3247226A1/en active Pending
- 2023-01-09 CN CN202380016646.6A patent/CN118524832A/zh active Pending
- 2023-01-09 JP JP2024541046A patent/JP2025502098A/ja active Pending
- 2023-01-09 EP EP23700341.3A patent/EP4463144A1/en active Pending
- 2023-01-09 WO PCT/IB2023/050172 patent/WO2023131922A1/en not_active Ceased
- 2023-01-09 US US18/727,745 patent/US20250090482A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Huang et al. | New treatment strategies of depression: based on mechanisms related to neuroplasticity | |
| Lee et al. | The effect of early neuromuscular electrical stimulation therapy in acute/subacute ischemic stroke patients with dysphagia | |
| JP2020180141A5 (cg-RX-API-DMAC7.html) | ||
| Block et al. | Emerging antidepressants to treat major depressive disorder | |
| RU2006140964A (ru) | Применение флибансерина для лечения предменструальных и иных сексуальных расстройств у женщин | |
| Akpinar et al. | Efficacy of transcranial magnetic stimulation in treatment-resistant depression | |
| CN107823195A (zh) | R‑氯胺酮在抑郁症急性期治疗中的应用 | |
| JP2025502098A5 (cg-RX-API-DMAC7.html) | ||
| JP2022552808A (ja) | Ｇａｂａ－ａ受容体陽性アロステリック調節因子と、ｎｍｄａ拮抗薬、ｎｍｄａ陰性アロステリック調節因子、またはｎｍｄａ部分作動薬との組み合わせ | |
| JP2022546456A5 (cg-RX-API-DMAC7.html) | ||
| RU2017107033A (ru) | Способы лечения депрессии с применением модуляторов nmda | |
| Stansbury et al. | The use of lobelia in the treatment of asthma and respiratory illness | |
| JP2025503649A5 (cg-RX-API-DMAC7.html) | ||
| US20240018231A1 (en) | Intranasal immunotherapt for the treatment of alzheimer's disease | |
| RU2024122072A (ru) | Композиции и способы лечения депрессии | |
| JP2025503646A5 (cg-RX-API-DMAC7.html) | ||
| Hagiu | Vasodilators, enhancers of prevention through exercise of COVID-19 | |
| Lee et al. | Studies on a novel regimen for management of orofacial pain and morphine tolerance | |
| Gersten et al. | Transcranial direct current stimulation (tDCS) for major depressive disorder | |
| MX2024003547A (es) | Metodos terapeuticos que usan hidrobromuro de bupropion | |
| Novák et al. | Repetitive transcranial magnetic stimulation (rTMS) in the treatment of bipolar depression | |
| Benussi et al. | Effects of cerebello-spinal stimulation in neurodegenerative ataxia on motor and cognitive outcomes: a randomized, double-blind, sham-controlled trial followed by an open-label phase | |
| Brainch et al. | D-Cycloserine: A Novel Antidepressant to Be Explored? | |
| GUO | Therapeutic effect of metoprolol tartrate on UAP and its influence on levels of blood lipids and inflam‐matory factors | |
| Zwanzger et al. | Repetitive transcranial magnetic stimulation in major depression—The impact of stimulation intensity on therapeutic efficacy |